Page last updated: 2024-08-21

levonorgestrel and gestodene

levonorgestrel has been researched along with gestodene in 86 studies

Research

Studies (86)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (17.44)	18.7374
1990's	38 (44.19)	18.2507
2000's	21 (24.42)	29.6817
2010's	12 (13.95)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C	1
Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Refn, H; Schierup, L	1
Hahn, DW; McGuire, JL; Phillips, A	1
Kuhnz, W	1
Hümpel, M; Li, QG	1
Borggaard, B; Kjaer, A; Lebech, AM; Refn, H; Schierup, L	1
Fotherby, K	1
Roy, S; Stanczyk, FZ	1
Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A	1
Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G	1
Jung-Hoffman, C; Kuhl, H	1
Juchem, M; Pollow, K	1
Maltau, JM; Oian, P; Omsjø, IH; Osterud, B	1
Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Pedersen, LR; Refn, H; Schierup, L	1
Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N	1
Florio, V; Morini, A; Mossa, B; Roscetti, C	1
Gaspard, UJ; Lepot, MR	1
Bonnar, J; Carroll, E; Daly, L	1
Harenberg, J; Kohlmeier, M; Rabe, T; Runnebaum, B; Weicker, H	1
Skouby, SO	1
Mall-Haefeli, M	1
Rabe, T; Runnebaum, B	1
Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M	1
Gillmer, MD	1
Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA	1
Düsterberg, B	1
Düsterberg, B; Hümpel, M; Speck, U	1
Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C	1
Kuhnz, W; Löfberg, B	1
Balogh, A; Börner, A; Henschel, L; Klinger, G; Kuhnz, W; Vollanth, R	1
Kuhnz, W; Schütt, B; Woloszczak, R	1
de Vries Robles-Korsen, TJ; Hemrika, DJ; Kennedy, JC; Schoemaker, J; Slaats, EH	1
Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G	1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG	2
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D	1
Jick, H; Jick, S; Myers, MW; Vasilakis, C	1
Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA	1
Farmer, RD; Lawrenson, R	1
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO	1
Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT	1
Lidegaard, O	1
Weiss, NS	1
Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP	1
Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R	1
Weiss, G	1
Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ	1
Chang, CL; Farley, TM; Marmot, MG; Meirik, O; Poulter, NR	1
Jick, H; Jick, SS; Myers, MW	1
Bouchoux, F; Degryse, M; Gaillard, M; Lecaque, D; Petit, F; Philibert, D	1
Koh, SC; Prasad, RN; Ratnam, SS; Viegas, OA	1
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S	1
Diab, KM; Zaki, MM	1
Buicu, C; Gaspard, U; van den Brûle, F	1
Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB	1
Meurer, LN; Slawson, JG	1
Berlin, JA; Hennessy, S; Kinman, JL; Marcus, SM; Margolis, DJ; Strom, BL	1
Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y	1
Dubey, RK; Jäger, AW; Keller, PJ; Merki-Feld, GS; Rosselli, M	1
García-Becerra, R; Gutiérrez-Sagal, R; Pasapera, AM; Savouret, JF; Ulloa-Aguirre, A	1
Algra, A; Bollen, EL; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y	1
Milsom, I; Odlind, V; Persson, I; Victor, A	1
Black, C; Jick, H; Kaye, JA	1
Hasegawa, M; Inês, M; Kassab, NM; Kedor-Hackmann, ER; Santoro, RM	1
Imthurn, B; Keller, PJ; Merki-Feld, GS	1
Alexandersen, P; Christiansen, C; Haarbo, J; Jespersen, J; Skouby, SO; Zandberg, P	1
Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G	1
Cagiano, R; Sabatini, R	1
Claeys, S; De Bodt, M; Van Cauwenberge, P; Van Lierde, KM	1
Kubán, V; Matejícek, D	1
Bjarnason, NH; Byrjalsen, I; Christiansen, C; Jørgensen, HL	1
Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW	1
Voelker, R	1
Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R	1
Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P	1
Heger-Mahn, D; Junge, W; Merz, M; Trummer, D	1
de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A	1
Bangerter, K; Kroll, R; Lynen, R; Merz, M	1
El-Haggar, SM; Mostafa, TM	1
Nelson, AL	1
Bachelot, A; Dureau, P; Funck-Brentano, C; Germain, M; Hulot, JS; Lebourgeois, B; Salem, JE; Trégouët, DA; Voiriot, P	1
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E	1

Reviews

6 review(s) available for levonorgestrel and gestodene

Article	Year
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids. Contraception, 1990, Volume: 42, Issue:1 Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes	1990
[What does the micropill bring?]. Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5 Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk	1986
[New forms of hormonal contraception]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2000, Volume: 29, Issue:3 Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds	2000
Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis. Contraception, 2001, Volume: 64, Issue:2 Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Venous Thrombosis	2001
Combined oral contraceptives: venous thrombosis. The Cochrane database of systematic reviews, 2014, Mar-03, Issue:3 Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis	2014
Transdermal contraception methods: today's patches and new options on the horizon. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:6 Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes	2015

Trials

23 trial(s) available for levonorgestrel and gestodene

Article	Year
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors. Contraception, 1991, Volume: 43, Issue:1 Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation	1991
Metabolic changes during treatment with two different progestogens. American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:1 Pt 2 Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Fertilization; Hormones; Humans; Levonorgestrel; Lipid Mobilization; Lipids; Menstrual Cycle; Norgestrel; Norpregnenes; Random Allocation; Reference Values	1990
Clinical and hormonal effects of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception, 1990, Volume: 41, Issue:3 Topics: Adult; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Radioimmunoassay; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin; Testosterone	1990
Low-dose oral contraceptives lower plasma levels of apolipoprotein E. European journal of obstetrics, gynecology, and reproductive biology, 1990, Volume: 37, Issue:2 Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides	1990
Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis. Acta obstetricia et gynecologica Scandinavica, 1989, Volume: 68, Issue:1 Topics: Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Norgestrel; Norpregnenes	1989
Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception, 1989, Volume: 40, Issue:6 Topics: Adult; Antithrombin III; Apolipoproteins A; Blood Coagulation; Cholesterol, HDL; Contraceptives, Oral, Combined; Factor VII; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Prospective Studies	1989
Effects of seven low-dose combined contraceptives on vitamin B6 status. Contraception, 1989, Volume: 40, Issue:3 Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors	1989
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents]. Minerva ginecologica, 1989, Volume: 41, Issue:11 Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes	1989
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol. International journal of fertility, 1987, Volume: 32 Suppl Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism	1987
Clinical and metabolic effects of gestodene and levonorgestrel. International journal of fertility, 1987, Volume: 32 Suppl Topics: Adolescent; Adult; Blood Glucose; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Stereoisomerism	1987
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study. International journal of fertility, 1987, Volume: 32 Suppl Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism	1987
Effects of three low-dose oral contraceptive formulations on lipid metabolism. Acta obstetricia et gynecologica Scandinavica, 1987, Volume: 66, Issue:4 Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation	1987
Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:1 Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norpregnenes	1995
Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination. European journal of clinical pharmacology, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Adult; Caffeine; Contraceptives, Oral; Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norpregnenes; Time Factors; Volunteers	1995
Effect of four combined oral contraceptives on blood pressure in the pill-free interval. Contraception, 1993, Volume: 47, Issue:4 Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors	1993
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group. Contraception, 1999, Volume: 59, Issue:6 Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis	1999
Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:1 Topics: Activated Protein C Resistance; Adolescent; Adult; Analysis of Variance; Antigens; Antithrombin III; beta-Thromboglobulin; Blood Platelets; Contraceptives, Oral, Synthetic; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Partial Thromboplastin Time; Peptide Fragments; Peptide Hydrolases; Plasminogen; Progesterone Congeners; Protein C; Protein S; Prothrombin; Thrombelastography; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; von Willebrand Factor	1999
Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A. The journal of obstetrics and gynaecology research, 2000, Volume: 26, Issue:1 Topics: Adult; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Norpregnenes; Prospective Studies	2000
Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women. Contraception, 2002, Volume: 65, Issue:3 Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Over Studies; Endothelin-1; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Nitric Oxide; Norpregnenes; Premenopause; Prospective Studies; Statistics, Nonparametric; Time Factors	2002
Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism. Metabolism: clinical and experimental, 2002, Volume: 51, Issue:9 Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Nitric Oxide; Norpregnenes	2002
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception, 2006, Volume: 74, Issue:3 Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage	2006
Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomize Drugs in R&D, 2013, Volume: 13, Issue:3 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Patient Compliance; Prothrombin Time; Transdermal Patch; Treatment Outcome; Young Adult	2013
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Contraception, 2015, Volume: 91, Issue:2 Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult	2015

Other Studies

57 other study(ies) available for levonorgestrel and gestodene

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin. Steroids, 1990, Volume: 55, Issue:8 Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone	1990
Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women. American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2 Topics: Adult; Contraceptives, Oral; Female; Half-Life; Humans; Japan; Levonorgestrel; Metabolic Clearance Rate; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin	1990
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man. Journal of steroid biochemistry, 1990, Volume: 35, Issue:2 Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats	1990
Potency and pharmacokinetics of gestagens. Contraception, 1990, Volume: 41, Issue:5 Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes	1990
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2 Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin	1990
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism. American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2 Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin	1990
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor. American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2 Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus	1990
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene. International journal of fertility, 1987, Volume: 32 Suppl Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism	1987
New progestogens in oral contraceptives. American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2 Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners	1987
Progestogen potency in oral contraceptive pills. American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2 Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners	1987
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception, 1988, Volume: 38, Issue:3 Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium	1988
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey. Steroids, 1984, Volume: 43, Issue:1 Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors	1984
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys. Contraception, 1981, Volume: 24, Issue:6 Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism	1981
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors	1995
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism	1995
Influence of changes in the concentration of sex hormone-binding globulin in human serum on the protein binding of the contraceptive steroids levonorgestrel, 3-keto-desogestrel and gestodene. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 48, Issue:5-6 Topics: Adult; Clinical Trials as Topic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin	1994
The effects of levonorgestrel, desogestrel and gestodene on the pulsatile release of luteinizing hormone in oral contraceptive users. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1993, Volume: 7, Issue:3 Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norpregnenes; Periodicity	1993
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1995
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured	1995
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2 Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires	1995
Risk of acute myocardial infarction and low-dose combined oral contraceptives. Lancet (London, England), 1996, Mar-02, Volume: 347, Issue:9001 Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Myocardial Infarction; Norpregnenes; Progesterone Congeners; Risk; Smoking	1996
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events. Contraception, 1995, Volume: 52, Issue:4 Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis	1995
Utilization patterns of oral contraceptives in UK general practice. Contraception, 1996, Volume: 53, Issue:4 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Family Practice; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; United Kingdom	1996
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception, 1996, Volume: 54, Issue:1 Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism	1996
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles. Contraception, 1996, Volume: 54, Issue:4 Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners	1996
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Acta obstetricia et gynecologica Scandinavica, 1997, Volume: 76, Issue:3 Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism	1997
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptives. Contraception, 1997, Volume: 55, Issue:3 Topics: Adolescent; Adult; Age Factors; Bias; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Research Design; Thrombophlebitis	1997
Risk of oral contraceptives and recency of market introduction. Contraception, 1997, Volume: 55, Issue:3 Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors	1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British journal of haematology, 1997, Volume: 97, Issue:1 Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis	1997
Risk of venous thromboembolism with third-generation oral contraceptives: A review. American journal of obstetrics and gynecology, 1999, Volume: 180, Issue:2 Pt 2 Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis	1999
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database. Human reproduction (Oxford, England), 1999, Volume: 14, Issue:6 Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis	1999
Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet (London, England), 1999, Jul-24, Volume: 354, Issue:9175 Topics: Adult; Case-Control Studies; Cerebrovascular Disorders; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors	1999
Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components. Lancet (London, England), 1999, Jul-24, Volume: 354, Issue:9175 Topics: Adult; Cerebral Hemorrhage; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Progesterone Congeners; Risk Factors	1999
The pharmacological profile of a novel norpregnance progestin (trimegestone). Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:5 Topics: Administration, Oral; Administration, Topical; Animals; Binding, Competitive; Endometrium; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone; Mice; Norethindrone; Norpregnenes; Progesterone Congeners; Promegestone; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Specific Pathogen-Free Organisms; Uterus	1999
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Human reproduction (Oxford, England), 2000, Volume: 15, Issue:4 Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis	2000
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP. British journal of pharmacology, 2000, Volume: 130, Issue:8 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation	2000
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? The Journal of family practice, 2001, Volume: 50, Issue:2 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis	2001
Oral contraceptives and the risk of myocardial infarction. The New England journal of medicine, 2001, Dec-20, Volume: 345, Issue:25 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking	2001
Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells. Endocrine, 2001, Volume: 16, Issue:3 Topics: Animals; Binding, Competitive; Cell Line; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Estrogens; Gene Expression; Genes, Reporter; Genetic Vectors; Kidney; Levonorgestrel; Mifepristone; Norethindrone; Norpregnenes; Progestins; Promegestone; Promoter Regions, Genetic; Rabbits; Receptors, Progesterone; Response Elements; Transcriptional Activation; Transfection	2001
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke, 2002, Volume: 33, Issue:5 Topics: Adolescent; Adult; Arterial Occlusive Diseases; Brain Ischemia; Case-Control Studies; Comorbidity; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Middle Aged; Netherlands; Norpregnenes; Odds Ratio; Risk Assessment; Risk Factors; Stroke; Surveys and Questionnaires; Thrombosis	2002
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta obstetricia et gynecologica Scandinavica, 2002, Volume: 81, Issue:6 Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis	2002
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. British journal of clinical pharmacology, 2002, Volume: 53, Issue:6 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis	2002
Determination of steroid hormones in oral contraceptives by high-performance liquid chromatography. Drug development and industrial pharmacy, 2002, Volume: 28, Issue:6 Topics: Calibration; Chromatography, High Pressure Liquid; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Progesterone Congeners	2002
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:7 Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Levonorgestrel; Norpregnenes; Progestins; Rabbits	2003
Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:1-2 Topics: Androgens; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Genes, Reporter; Genetic Vectors; HeLa Cells; Humans; Levonorgestrel; Ligands; Nandrolone; Norethindrone; Norpregnenes; Plasmids; Progestins; Protein Biosynthesis; Receptors, Androgen; Receptors, Progesterone; Transcription, Genetic; Transcriptional Activation; Transfection; Trypsin	2004
Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach. The Laryngoscope, 2006, Volume: 116, Issue:10 Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norpregnenes; Phonation; Speech Acoustics; Voice; Voice Disorders; Voice Quality	2006
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel. Analytica chimica acta, 2007, Apr-11, Volume: 588, Issue:2 Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet	2007
The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:2 Topics: Administration, Oral; Contraceptive Agents; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Smoking; Uterine Hemorrhage	2007
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ (Clinical research ed.), 2011, Oct-25, Volume: 343 Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult	2011
Risk of blood clots higher for oral contraceptives with certain progestins. JAMA, 2011, Nov-23, Volume: 306, Issue:20 Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism	2011
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives. Contraception, 2013, Volume: 88, Issue:1 Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors	2013
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2013, Volume: 18, Issue:4 Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult	2013
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study. Endocrine, 2015, Volume: 49, Issue:3 Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors	2015
Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women. JAMA cardiology, 2018, 09-01, Volume: 3, Issue:9 Topics: Administration, Oral; Adult; Androgen Antagonists; Androstenes; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Europe; Female; Humans; Levonorgestrel; Logistic Models; Long QT Syndrome; Norpregnenes; Sotalol; Young Adult	2018
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12 Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism	2018